The first Paxil lawsuit against GlaxoSmithKline over alleged birth defects caused by the antidepressant is scheduled for trial to begin today in Philadelphia. This is one of approximately 600 similar claims involving heart defects and other injuries suffered by babies born to woman who used Paxil. The birth injury lawsuit claims that the use of Paxil resulted in life-threatening heart defects in her three-year-old son. Paxil is a selective serotonin reuptake inhibitor prescribed to treat depression. It is one of the most common drugs prescribed in the Untied States. The plaintiffs claimed that GlaxoSmithKline knew about the potential for Paxil to cause birth defects, but hid data and failed to warn users of the potential birth defect side effects. The FDA released an alert in 2005 that studies showed that the drug could increase the risk of heart defects in infants when taken during the first three months of pregnancy. It then required the company to update Paxil label warnings to include the risk of birth defects. The company says there is no conclusive evidence that Paxil causes birth defects, and intend to argue that the injury suffered by the plaintiff’s son was not caused by the use of Paxil. The plaintiff’s son was born with holes in his heart that had to be addressed with multiple surgeries before he was six months old, which the birth defect lawsuit says is the result of the Paxil. To read more about the birth injury lawsuit, please click the link.